Reports and Briefs on Pharmaceuticals and Healthcare in South Korea

Published within

« | 1 | 2 | » »|

Type Product title / description Pub Price
Report
Report

Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan

This report discusses four key Asian vaccines markets, India, China, South Korea and Taiwan. It analyzes the commercial and regulatory environment, guidelines, domestic and multinational competition as well as current and future indications.

Published By Datamonitor
02 Nov 2009 $3800
Buy
Report
Report

Stakeholder Insight: Hepatitis B & C in Asia - Tapping the opportunity of high prevalence rates in China, Taiwan, South Korea and Turkey

China, Taiwan, South Korea and Turkey represent highly endemic areas for viral Hepatitis, but little is known about therapy dynamics and drivers of treatment choice. Particularly in China, a high emphasis on efficacy as well as cost leads to continued use of inexpensive, but suboptimal treatment approaches. For this report, 180 high-prescribing physicians where surveyed in these countries, providing a breakdown of patients numbers, frequently prescribed regimens and brand perceptions.

Published By Datamonitor
15 Feb 2010 $15200
Buy
Report
Report

Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions

An overview of merger and acquisition (M&A) trends in developed and emerging pharmaceutical markets in the Asia-Pacific region from Q1 2007 to Q1 2010, with discussion of the drivers of recent deals and analysis of key M&As in individual countries.

Published By Datamonitor
19 Aug 2010 $7600
Buy
Report
Report

Pharmaceutical Licensing and Alliances in the Asia-Pacific Region – Pharma enhances its focus on APAC markets

An overview of licensing and alliance trends in developed and emerging pharmaceutical markets in the Asia-Pacific region from Q3 2009 to Q2 2010, including discussion of the drivers of recent deals and analysis of key agreements.

Published By Datamonitor
19 Nov 2010 $7600
Buy
Premium Report
Premium Report

Pharmaceuticals in South Korea - Industry and Country Analysis

Pharmaceuticals in South Korea - Industry and Country Analysis provides five forces Industry analysis, along with PESTLE country analysis of South Korea This report concludes with profiles of the leading companies in the Korean pharmaceuticals market

Published By Datamonitor
28 Jul 2011 $395
Buy
Report
Report

South Korea: Healthcare System and Drug Regulatory Overview

This report provides an overview of healthcare expenditure, the insurance and healthcare system, healthcare reforms, drug regulation and intellectual property, and drug pricing and reimbursement in South Korea.

Published By Datamonitor
28 Jul 2011 $1900
Buy
Report
Report

South Korea: Pharmaceutical Industry Infrastructure Overview

This report provides an overview of research and development, manufacturing, outsourcing, and distribution trends, as well as infrastructure profiles for the leading pharmaceutical companies in South Korea.

Published By Datamonitor
28 Jul 2011 $1900
Buy
Report
Report

South Korea: Generics and Biosimilars Overview

This report provides an overview of the generics and biosimilars landscape in South Korea, including regulatory issues, drivers and resistors to uptake, level of penetration, and key players operating in the market.

Published By Datamonitor
08 Aug 2011 $1900
Buy
Report
Report

Pharmaceutical M&A in the Asia Pacific Region

An overview of merger and acquisition (M&A) trends in developed and emerging pharmaceutical markets in the Asia Pacific region from Q1 2007 to Q2 2011, with discussion of the drivers of recent deals and analysis of key M&As in individual countries.

Published By Datamonitor
24 Nov 2011 $7600
Buy
Report
Report

Orphan Drug Trends

Datamonitor’s report Orphan Drug Trends provides an overview of orphan drug regulations in the major pharmaceutical markets, including pricing and reimbursement issues and an analysis of Big Pharma’s growing interest in orphan drugs.

Published By Datamonitor
25 Nov 2011 $5700
Buy

« | 1 | 2 | » »|

No help is available.